Medical Oncologist
CION Cancer Clinics
BRIP1 mutation: which cancers, and how much risk | CION Cancer Clinics
A harmful BRIP1 fault mainly raises the risk of ovarian cancer, and less sharply than BRCA1 or BRCA2 do. The evidence for breast and other cancers is much weaker. This page sets out what is known for each organ, how your own risk is judged, how BRIP1 compares with BRCA, and what a result means for the men in your family. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Which cancers does a BRIP1 fault raise the risk of?
- What is known about each cancer
- How a counsellor judges your own BRIP1 risk
- The words you will meet, in plain language
- How BRIP1 compares with BRCA1 and BRCA2
- Four things families tell us, and what is actually true
- What this page cannot tell you
- Common questions about BRIP1 risks
The short answer
Which cancers does a BRIP1 fault raise the risk of?
The clearest risk is ovarian cancer. A woman carrying a harmful BRIP1 fault has a higher lifetime chance of ovarian cancer than other women, though lower than with BRCA1 or BRCA2. For breast cancer and other cancers the evidence is much weaker, and most guidelines do not change breast screening on a BRIP1 result alone.
Why BRIP1 is called a moderate-risk gene
Genes linked to inherited cancer are often grouped by how much they raise risk. BRCA1 and BRCA2 are high-risk genes. BRIP1 sits a step below. That matters because the plan offered to a BRIP1 carrier is lighter and starts later than the plan for a BRCA carrier.
Why the answer is still being refined
BRIP1 was added to testing panels much more recently than BRCA. Fewer carriers have been followed over their lives, so risk estimates are wider and change as studies grow. Indian data in particular are still thin. We would rather tell you that plainly than give you a firm-looking number that may not hold.
Why relatives in the same family matter
In Telangana many families are large, and in some communities partners are related before marriage. Both of these can matter for BRIP1. A large family means more relatives who could benefit from a simple targeted test. Related partners are more likely to both carry the same fault, which changes what a couple needs to know before a pregnancy.
A BRIP1 result is a statement about risk. It is not a diagnosis, and many carriers never develop cancer.Organ by organ
What is known about each cancer
The strength of the evidence differs a great deal from one organ to the next.
Ovarian cancer
The link is well established. The risk rises mainly after the menopause, which is why any discussion of removing the tubes and ovaries comes later than for BRCA carriers.
Evidence
- Confirmed in several large studies
- Recognised in international guidelines
Breast cancer
Early studies suggested a link, but larger ones have not confirmed a clear rise. Breast screening is usually based on your family history, not on the BRIP1 result itself.
Other cancers
Links to prostate and other cancers have been reported, but the studies are small and not consistent. No extra screening is routinely offered for them.
Men
A man with BRIP1 has no clearly proven raised risk himself. His result matters because he can pass it to his daughters.
A father passes it with a one in two chance to each child.Not sure whether this applies to you?
Ask an oncologistHow it is worked out
How a counsellor judges your own BRIP1 risk
Confirming the variant
The counsellor first checks that the change is classed as pathogenic or likely pathogenic, meaning known to be harmful. An uncertain variant does not count.
Drawing the family tree
Who had ovarian or breast cancer, on which side, and how young. A strong family history can raise your estimate above the average for the gene.
Your age and stage of life
Risk that sits mostly after the menopause means a woman in her twenties has time to plan, while a woman in her fifties may need decisions sooner.
Other factors
Pregnancies, use of the contraceptive pill and earlier surgery on the ovaries can all shift ovarian risk a little in either direction.
A written summary
You should leave with a plain summary of your risk, your options and who in the family should be offered testing.
On your report
The words you will meet, in plain language
- BRIP1
- A gene that works alongside BRCA1 to repair broken DNA. A harmful fault weakens that repair.
- Moderate-penetrance gene
- A gene whose faults raise risk, but less sharply than the best-known high-risk genes. Penetrance means how often a fault leads to cancer.
- Pathogenic variant
- A change in the gene known to break it. This is what people mean by a positive result.
- Germline
- Present in every cell from birth, so it can be inherited. A fault found only in a tumour is somatic and belongs under targeted therapy.
- Carrier
- Someone with the fault but no cancer. A carrier needs a plan, not treatment.
- Biallelic
- A faulty copy inherited from both parents. For BRIP1 this causes a rare childhood bone-marrow condition and is very different from carrying one copy.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
How BRIP1 compares with BRCA1 and BRCA2
BRIP1
BRCA1 and BRCA2
Raised ovarian risk, mainly after the menopause
Higher ovarian risk, starting younger
No clearly proven rise in breast risk
A substantially raised breast risk
Ovary removal discussed in the mid-forties or later
Ovary removal discussed earlier
Breast screening set by family history
Yearly breast MRI from a young age
Commonly believed
Four things families tell us, and what is actually true
"BRIP1 is just another name for BRCA."
It is a different gene with a different, smaller set of risks. Applying BRCA advice to a BRIP1 carrier can lead to surgery or scans that are not needed.
"A BRIP1 fault means I will get breast cancer."
The strongest evidence is for ovarian cancer. Breast risk has not been clearly shown to rise, and many carriers never develop either cancer.
"My brother is a man, so his result does not matter."
He may carry the fault without any risk to himself, and pass it to his daughters. Men belong in the family testing plan.
"Nobody had ovarian cancer, so it can't be real."
A moderate-risk gene often leaves no obvious pattern, especially in small families or where women had their ovaries removed for other reasons.
Being straight with you
What this page cannot tell you
It cannot give you a personal risk figure. Estimates for BRIP1 still vary between studies, and your family history can move your own figure up or down. What your specific variant means is a question for the counsellor who ordered the test.
It cannot decide on surgery for you
Whether and when to remove the tubes and ovaries depends on your age, your family plans, your health and your own view of the risk. That is a conversation for a gynaecologic oncologist and a counsellor, over more than one visit if you need it.
Who this does not apply to
This page is for people with a confirmed harmful BRIP1 fault. It does not apply to a variant of uncertain significance, or to a relative who tested negative for the family's fault. Most people never need a BRIP1 test at all.
If your report mentions BRIP1 and you are unsure what it says, call the helpline and ask for a counselling appointment.Questions we are asked
Common questions about BRIP1 risks
Is BRIP1 as serious as BRCA?
No. It raises ovarian cancer risk, but less than BRCA1 or BRCA2, and it has no clearly proven effect on breast risk. That is why the plan for a BRIP1 carrier is lighter and starts later. It is still worth acting on.
Do I need breast MRI because of BRIP1?
Usually not on the gene alone. Breast screening for a BRIP1 carrier is normally set by the family history. If several relatives had breast cancer young, your doctor may still offer earlier or extra checks.
Can ovarian cancer be found early with scans?
Not reliably. Ultrasound and the CA-125 blood test have not been shown to find it early enough to rely on. This is why surgery to remove the tubes and ovaries is discussed for carriers once their family is complete.
Does BRIP1 affect my treatment if I already have ovarian cancer?
It may. Some medicines work better in cancers with weak DNA repair, and your oncologist will weigh the result alongside tumour tests. Tumour testing itself is covered under targeted therapy.
Should my daughter be tested now?
Usually not while she is a child. BRIP1 risk falls mainly in later adult life, so testing normally waits until she can decide for herself. There is plenty of time to plan.
My husband and I both carry BRIP1. What does that mean for our children?
Each child could inherit a faulty copy from both of you, which causes a rare, serious childhood condition. This is more likely in families where partners are related. See a counsellor as a couple before or during a pregnancy.
Is there an Indian study of BRIP1 risk?
BRIP1 appears in Indian panel studies, but they mostly count how often it is found rather than following carriers over time. Risk advice in India still relies largely on international data.
Can lifestyle lower my risk?
No change in diet or habit has been shown to remove the extra risk from BRIP1. Not smoking, staying active and keeping a healthy weight are good for you anyway. The bigger decisions are about surveillance and surgery timing.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- MedlinePlus Genetics — BRIP1 gene
- National Cancer Institute (PDQ) — Genetics of Breast and Gynecologic Cancers (PDQ) – Health Professional Version
- NCCN Guidelines for Patients — Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers
- Cancer Research UK — Risks and causes of ovarian cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
The BRIP1 gene: what it doesWhat the gene normally does, before the risksBRIP1 positive: what happens nextThe practical steps after a positive resultSurveillance for BRIP1 carriersWhich checks are offered, and which are notWhich genes cause HBOC besides BRCAWhere BRIP1 sits among the other ovarian genes
Talk to us
Holding a BRIP1 result and not sure what it means?
Bring your report and a list of relatives who had cancer. A genetic counsellor will explain what the result means for you and who else in the family should be offered a test. One helpline serves every CION centre.